[1] Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. The Lancet, 2012, 379(9818):0-822.
[2] U.S. Renal Data System. 2008 Annual Data Report:Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.Bethesda,MD：National Institutes of Health,2007.
[3] NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. [J] .Am. J. Kidney Dis., 1997, 30: S150-91.
[4] National Kidney Foundation: III. NKF-K/DOQI clinical practice guidelines for vascular access: Update 2000. Am J KidneyDis : S137–S181, 2001
[5] Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access: Am J Kidney Dis : S176–S273, 2006
[6] National Kidney Foundation Kidney Disease Outcomes and Quality Initiative(KDOQI). Clinical Practice Guidelines for Hemodialysis Adequacy.
[7] Pisoni R L , Young E W , Dykstra D M , et al. Vascular access use in Europe and the United States: results from the DOPPS.[J]. Kidney International, 2002, 61(1):305-316.
[8] Woo K, Lok C E. New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients [J]. Clinical Journal of the American Society of Nephrology Cjasn, 2016, 11(8):1487.
[9] Richardson Ii A I , Leake A , Schmieder G C , et al. Should fistulas really be first in the elderly patient [J]. Journal of Vascular Access, 2009, 10(3):199.
[10] Lazarides M K , Georgiadis G S , Antoniou G A , et al. A meta-analysis of dialysis access outcome in elderly patients[J]. JOURNAL OF VASCULAR SURGERY, 2007, 45(2):420-42600.
[11] Jeong Seonjeong,Kwon Hyunwook,Chang Jai Won et al. Patency rates of arteriovenous fistulas created before versus after hemodialysis initiation.[J] .PLoS ONE, 2019, 14: e0211296.
[12] Hall R K , Myers E R , Rosas S E , et al. Choice of Hemodialysis Access in Older Adults: A Cost-Effectiveness Analysis[J]. Clinical Journal of the American Society of Nephrology, 2017:CJN.11631116.
[13] Thamer Mae,Lee Timmy C,Wasse Haimanot et al. Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.[J] .Am. J. Kidney Dis., 2018, 72: 10-18.
[14] Lee T , Allon M . Reassessing Recommendations for Choice of Vascular Access[J]. Clinical Journal of the American Society of Nephrology, 2017:CJN.04070417.
[15] 段小婷. 不同血管通路对血液透析患者透析充分性影响的探讨[D].石河子大学,2013.
[16] 王捷.血液透析患者血管通路使用情况及影响因素分析[J].中外医学研究,2018,16(18):166-168.
[17] 王玉柱, 叶朝阳, 金其庄. 中国血液透析用血管通路专家共识(第1版)[J]. 中国血液净化, 2014, 13(8):549-558.
[18] 周翔.对首次接受血液透析治疗的尿毒症患者使用血管通路情况的调查[J].当代医药论丛,2018,16(06):149-150.
[19] 冯雪芳,周蓉,徐雅虹,蒋茜,陈闽东,沈杰.上海市单中心糖尿病血液透析血管通路调查分析[J].中国血液净化,2016,15(08):430-432.
[20] 崔宁,欧阳凌霞,范汪洋,施翎,吕敏,唐莉,姜继光,陈其军.单中心血液透析患者血管通路的调查分析[J].现代实用医学,2016,28(04):427-430.
